FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1930742983> ?p ?o ?g. }

• W1930742983 endingPage "80" @default.
• W1930742983 startingPage "973" @default.
• W1930742983 abstract "The combination of hydroxycitrate and lipoic acid has been demonstrated by several laboratories to be effective in reducing murine cancer growth.All patients had failed standard chemotherapy and were offered only palliative care by their referring oncologist. Karnofsky status was between 50 and 80. Life expectancy was estimated to be between 2 and 6 months. Ten consecutive patients with chemoresistant advanced metastatic cancer were offered compassionate metabolic treatment. They were treated with a combination of lipoic acid at 600 mg i.v. (Thioctacid), hydroxycitrate at 500 mg t.i.d. (Solgar) and low-dose naltrexone at 5 mg (Revia) at bedtime. Primary sites were lung carcinoma (n=2), colonic carcinoma (n=2), ovarian carcinoma (n=1), esophageal carcinoma (n=1), uterine sarcoma (n=1), cholangiocarcinoma (n=1), parotid carcinoma (n=1) and unknown primary (n=1). The patients had been heavily pre-treated. One patient had received four lines of chemotherapy, four patients three lines, four patients two lines and one patient had received radiation therapy and chemotherapy. An eleventh patient with advanced prostate cancer resistant to hormonotherapy treated with hydroxycitrate, lipoic acid and anti-androgen is also reported.One patient was unable to receive i.v. lipoic acid and was switched to oral lipoic acid (Tiobec). Toxicity was limited to transient nausea and vomiting. Two patients died of progressive disease within two months. Two other patients had to be switched to conventional chemotherapy combined with metabolic treatment, one of when had a subsequent dramatic tumor response. Disease in the other patients was either stable or very slowly progressive. The patient with hormone-resistant prostate cancer had a dramatic fall in Prostate-Specific Antigen (90%), which is still decreasing.These very primary results suggest the lack of toxicity and the probable efficacy of metabolic treatment in chemoresistant advanced carcinoma. It is also probable that metabolic treatment enhances the efficacy of cytotoxic chemotherapy. These results are in line with published animal data. A randomized clinical trial is warranted." @default.
• W1930742983 created "2016-06-24" @default.
• W1930742983 creator A5016012559 @default.
• W1930742983 creator A5029902285 @default.
• W1930742983 creator A5058311487 @default.
• W1930742983 creator A5078550481 @default.
• W1930742983 creator A5080432678 @default.
• W1930742983 date "2014-02-01" @default.
• W1930742983 modified "2023-10-10" @default.
• W1930742983 title "Metabolic treatment of cancer: intermediate results of a prospective case series." @default.
• W1930742983 cites W1593662473 @default.
• W1930742983 cites W1966447268 @default.
• W1930742983 cites W1969836970 @default.
• W1930742983 cites W1969913876 @default.
• W1930742983 cites W1972415853 @default.
• W1930742983 cites W1975854213 @default.
• W1930742983 cites W1982655087 @default.
• W1930742983 cites W1989438670 @default.
• W1930742983 cites W1994291650 @default.
• W1930742983 cites W2002390003 @default.
• W1930742983 cites W2003863419 @default.
• W1930742983 cites W2020993937 @default.
• W1930742983 cites W2021881204 @default.
• W1930742983 cites W2028897202 @default.
• W1930742983 cites W2030442612 @default.
• W1930742983 cites W2030520122 @default.
• W1930742983 cites W2034358365 @default.
• W1930742983 cites W2037566862 @default.
• W1930742983 cites W2038444072 @default.
• W1930742983 cites W2043354325 @default.
• W1930742983 cites W2043540590 @default.
• W1930742983 cites W2043680485 @default.
• W1930742983 cites W2045406685 @default.
• W1930742983 cites W2048752000 @default.
• W1930742983 cites W2065417819 @default.
• W1930742983 cites W2072451938 @default.
• W1930742983 cites W2080977352 @default.
• W1930742983 cites W2084056235 @default.
• W1930742983 cites W2086290265 @default.
• W1930742983 cites W2088795854 @default.
• W1930742983 cites W2096370575 @default.
• W1930742983 cites W2097259163 @default.
• W1930742983 cites W2098143217 @default.
• W1930742983 cites W2099616702 @default.
• W1930742983 cites W2101540330 @default.
• W1930742983 cites W2107609234 @default.
• W1930742983 cites W2118604693 @default.
• W1930742983 cites W2121286031 @default.
• W1930742983 cites W2126241051 @default.
• W1930742983 cites W2130503287 @default.
• W1930742983 cites W2137083729 @default.
• W1930742983 cites W2154981466 @default.
• W1930742983 cites W2156291382 @default.
• W1930742983 cites W2161128788 @default.
• W1930742983 cites W2169983443 @default.
• W1930742983 cites W2279169959 @default.
• W1930742983 cites W2355070788 @default.
• W1930742983 cites W3142537601 @default.
• W1930742983 cites W44342592 @default.
• W1930742983 cites W2183124139 @default.
• W1930742983 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24511042" @default.
• W1930742983 hasPublicationYear "2014" @default.
• W1930742983 type Work @default.
• W1930742983 sameAs 1930742983 @default.
• W1930742983 citedByCount "13" @default.
• W1930742983 countsByYear W19307429832015 @default.
• W1930742983 countsByYear W19307429832016 @default.
• W1930742983 countsByYear W19307429832017 @default.
• W1930742983 countsByYear W19307429832018 @default.
• W1930742983 countsByYear W19307429832019 @default.
• W1930742983 countsByYear W19307429832020 @default.
• W1930742983 countsByYear W19307429832022 @default.
• W1930742983 countsByYear W19307429832023 @default.
• W1930742983 crossrefType "journal-article" @default.
• W1930742983 hasAuthorship W1930742983A5016012559 @default.
• W1930742983 hasAuthorship W1930742983A5029902285 @default.
• W1930742983 hasAuthorship W1930742983A5058311487 @default.
• W1930742983 hasAuthorship W1930742983A5078550481 @default.
• W1930742983 hasAuthorship W1930742983A5080432678 @default.
• W1930742983 hasConcept C121608353 @default.
• W1930742983 hasConcept C126322002 @default.
• W1930742983 hasConcept C141071460 @default.
• W1930742983 hasConcept C143998085 @default.
• W1930742983 hasConcept C2776694085 @default.
• W1930742983 hasConcept C2778822529 @default.
• W1930742983 hasConcept C71924100 @default.
• W1930742983 hasConcept C90924648 @default.
• W1930742983 hasConceptScore W1930742983C121608353 @default.
• W1930742983 hasConceptScore W1930742983C126322002 @default.
• W1930742983 hasConceptScore W1930742983C141071460 @default.
• W1930742983 hasConceptScore W1930742983C143998085 @default.
• W1930742983 hasConceptScore W1930742983C2776694085 @default.
• W1930742983 hasConceptScore W1930742983C2778822529 @default.
• W1930742983 hasConceptScore W1930742983C71924100 @default.
• W1930742983 hasConceptScore W1930742983C90924648 @default.
• W1930742983 hasIssue "2" @default.
• W1930742983 hasLocation W19307429831 @default.
• W1930742983 hasLocation W19307429832 @default.

• next